Last reviewed · How we verify
NCT06619535
Sepsis As a Cause of Death Among Elderly Cancer Patients
trial in Sepsis in 5,239,194 participants. Completed in 30 December 2021.
30 December 2021
Quick facts
| Lead sponsor | asmaa salama ibrahim |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,239,194 |
| Start date | 1 January 2000 |
| Primary completion | 30 December 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across Egypt |
Conditions studied
Sponsor
asmaa salama ibrahim
Who can join
65 and older, any sex, with Sepsis or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this retrospective study is to explore the association between sepsis and morality among the elderly cancer patients. Data were extracted from the Surveillance, Epidemiology and End Results( SEER) database using SEER\*stat software. The study included patients aged 65 years or more who were diagnosed with cancer from 2000 to 2021. The extracted data included age, race, marital status, sex, stage, surgery, chemotherapy and radiotherapy. Multiple primary session was used to calculate the standardized Mortality ratio (SMR) as Observed/Expected with excess risk/10,000 and significance was achieved at 0.05.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sepsis as a cause of death among elderly cancer patients: an updated SEER database analysis 2000-2021.
Ellaithy I, Elshiekh H, Elshennawy S, Elshenawy S, et al · · 2025 · cited 2× · PMID 40212191 · DOI 10.1097/ms9.0000000000003144
Verify or expand the search:
- PubMed search for NCT06619535
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other asmaa salama ibrahim trials
Trials by the same sponsor.
- NCT06620926 — Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma · completed
- NCT06659224 — The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma · completed
- NCT06978595 — Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies · completed
- NCT06662734 — Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06619535 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by asmaa salama ibrahim
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06619535.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing